Advertisement
Clinicians should individualize dosing practices based on patient risk factors and preferences
Results inform dose selection for further trials of the aldosterone synthase inhibitor
Home transmission to the medical record, plus ambulatory monitoring for high-risk patients
Retrospective clinic-based study provides intriguing initial comparisons
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A clinical hypertension specialist puts recommendations in context
Three Cleveland Clinic cardiologists size up the ACC/AHA recommendations
Celecoxib has least impact, followed by naproxen and ibuprofen
Advertisement
Advertisement